Andreia Peixoto

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics

Céu Costa, Sofia Pereira, Luís Lima et al. · PLoS ONE · 2015 · 73 citations · Full text

Urology, Abnormal Protein Glycosylation, Mtor-pathway Inhibitor Sirolimus +14

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein<i>O</i>-glycosylation extension

Andreia Peixoto, Elisabete Fernandes, Cristiana Gaiteiro et al. · Oncotarget · 2016 · 70 citations · Full text

Malignant Nature, Glycobiology, Pathology +21

Targeted <i>O</i>‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours

Sofia Cotton, Rita Azevedo, Cristiana Gaiteiro et al. · Molecular Oncology · 2017 · 63 citations · Full text

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications

Rita Azevedo, Cristiana Gaiteiro, Andreia Peixoto et al. · Clinical Proteomics · 2018 · 53 citations · Full text

Cd44 Role, Cd44 Nomenclature, Glycobiology +20

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases

Luís Lima, Manuel Neves, Marta I. Oliveira et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 47 citations

Urology, Luminal Subtypes, Genitourinary Cancer +7